These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 9287250)

  • 1. MHC-derived peptides and the CD4+ T-cell repertoire: implications for autoimmune disease.
    Baum H; Staines NA
    Cytokines Cell Mol Ther; 1997 Jun; 3(2):115-25. PubMed ID: 9287250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC and T cell development.
    Viret C; Janeway CA
    Rev Immunogenet; 1999; 1(1):91-104. PubMed ID: 11256575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Binding-peptide motifs of HLA class II molecules susceptible to autoimmune diseases].
    Nishimura Y
    Nihon Rinsho; 1997 Jun; 55(6):1384-96. PubMed ID: 9200922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens.
    Shigematsu H; Shimoda S; Nakamura M; Matsushita S; Nishimura Y; Sakamoto N; Ichiki Y; Niho Y; Gershwin ME; Ishibashi H
    Hepatology; 2000 Nov; 32(5):901-9. PubMed ID: 11050037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity.
    Fu Y; Nathan DM; Li F; Li X; Faustman DL
    J Clin Invest; 1993 May; 91(5):2301-7. PubMed ID: 8486790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peptidic self model: a reassessment of the role of the major histocompatibility complex molecules in the restriction of the T-cell response.
    Claverie JM; Kourilsky P
    Ann Inst Pasteur Immunol; 1986; 137D(3):425-42. PubMed ID: 3103648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionarily conserved antigens in autoimmune disease: implications for an infective aetiology.
    Wegner N; Wait R; Venables PJ
    Int J Biochem Cell Biol; 2009 Feb; 41(2):390-7. PubMed ID: 18926919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain.
    Iwai LK; Juliano MA; Juliano L; Kalil J; Cunha-Neto E
    J Autoimmun; 2005 Mar; 24(2):111-7. PubMed ID: 15829403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In the normal repertoire of CD4+ T cells, a single class II MHC/peptide complex positively selects TCRs with various antigen specificities.
    Chmielowski B; Muranski P; Ignatowicz L
    J Immunol; 1999 Jan; 162(1):95-105. PubMed ID: 9886374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is primary biliary cirrhosis a model autoimmune disease?
    Ichiki Y; Shimoda S; Ishibashi H; Gershwin ME
    Autoimmun Rev; 2004 Jun; 3(4):331-6. PubMed ID: 15246030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.
    Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A
    Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A study on mechanisms of thymic selection by intrathymic administration of antigenic peptides].
    Nishihori H
    Hokkaido Igaku Zasshi; 1997 Sep; 72(5):517-28. PubMed ID: 9363468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive mycobacterial and self hsp60 epitope recognition in I-A(g7) expressing NOD, NOD-asp and Biozzi AB/H mice.
    van Halteren AG; Roep BO; Gregori S; Cooke A; van Eden W; Kraal G; Wauben MH
    J Autoimmun; 2002 Mar; 18(2):139-47. PubMed ID: 11908946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An HLA-binding-motif-aided peptide epitope library: a novel library design for the screening of HLA-DR4-restricted antigenic peptides recognized by CD4+T cells.
    Tana T; Kamikawaji N; Savoie CJ; Sudo T; Kinoshita Y; Sasazuki T
    J Hum Genet; 1998; 43(1):14-21. PubMed ID: 9609993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of molecular mimicry.
    Wucherpfennig KW
    J Autoimmun; 2001 May; 16(3):293-302. PubMed ID: 11334495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.